SEEGENE
Live / Registered — Registered (as of 31 Jan 2023)
What this means for you
Registered since 31 Jan 2023. The owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 79323815
- Registration number
- 6966080
- Mark type
- Stylized text
- Filed
- 06 Jul 2021
- Published for opposition
- 15 Nov 2022
- Registered
- 31 Jan 2023
- Attorney of record
- Max Vern
Goods and services
- Class 042 — Scientific and technological services: Research and development in the field of special testing using genetic engineering; biological services, namely, testing and analysis of biological samples in research laboratories; research and development of DNA chips; structural and functional analysis of genomes; biotechnological research; advisory services relating to biotechnological research; biological research; biochemical analysis; biochemical research; research in the field of gene analysis; genetic research; chemical analysis; research in the field of chemistry; chemical research and analysis; chemical research; research and development of vaccines and medicines; crude drugs research; research on adult diseases; bacteriological research; scientific research for medical purposes in the field of cancerous diseases; research relating to medicines; pharmaceutical products evaluation; consultancy pertaining to pharmacology; testing of pharmaceuticals; pharmaceutical research; medical research; medical science research in the field of clinical pathology and special examination; scientific research in the nature of conducting clinical trials for others; medical research and technical diagnostic testing services for evaluating clinical trial progress; medical research laboratory services for predicting disease; medical laboratory services, namely, preparation and analysis of human body tissue and fluid samples, providing reports respecting the same; research and development of infectious disease diagnosis products; research and development agency of infectious disease diagnosis products; research and development of bacterial and virus test products; research and development agency of bacterial and virus test products; research and development of genetic disease diagnosis products; research and development agency of genetic disease diagnosis products; research and development of blood analysis; research and development agency of blood analysis; research and development agency of cell test products for medical research, treatment, and diagnosis; research and development of cell test products for medical research, treatment, and diagnosis; research and development of body fluid and tissue sample analysis products for medical research, treatment, and diagnosis; research and development agency of body fluid and tissue sample analysis products for medical research, treatment, and diagnosis
- Class 044 — Medical, beauty and agricultural services: Pharmaceutical advice; pharmacy advice in the field of preparation of prescriptions in pharmacies; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products; providing medical information relating to diagnostic, prophylactic and therapeutic properties of medical products via the Internet; telemedicine services; medical services; medical information services provided via the Internet; medical and pharmaceutical consultation; medical testing services, namely, medical diagnostic testing; medical testing for diagnostic or treatment purposes; medical cancer testing for diagnostic or treatment purposes; genetic testing for medical purposes; healthcare services through the Internet; consulting services in the field of health management in the nature of managing health conditions through the internet; medical clinical pathology examination; health checkup and information services related thereto; medical clinical test in the nature of diagnostic testing and genetic testing for treatment purposes and information services related thereto; providing collected and managed medical information and personal health information; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation; medical screening and examining services for disease prevention of cancer, infectious disease by pathogens and genetic disease by mutation to improve health culture; healthcare; health counselling; physical examination services; hospital services, not including dentistry services; medical clinic services, not including dentistry services; telemedicine services, not including dentistry services; rental of medical and health care equipment; medical assistance services; medical consultation services, not including dentistry services; medical equipment rental; providing health information services, not including dentistry services; health center services; performing diagnosis of diseases; medical and diagnostic services, namely, identifying hereditary risk factors; medical and medical diagnostic services for disease prevention; medical and diagnostic services, namely, diagnosing in the nature of in vitro diagnostic services for medical purposes; medical analysis services relating to the treatment of persons, namely, analysis of human bodily fluid and tissue samples for diagnostic and treatment services provided by a medical laboratory
Owner
- SEEGENE, INC., KR
- SEEGENE, INC., KR
- SEEGENE, INC., KR
Prosecution history
- 30 May 2023 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 04 May 2023 — FINAL DISPOSITION NOTICE SENT TO IB
- 04 May 2023 — FINAL DISPOSITION PROCESSED
- 30 Apr 2023 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 31 Jan 2023 — NOTICE OF REGISTRATION CONFIRMATION EMAILED
- 31 Jan 2023 — REGISTERED-PRINCIPAL REGISTER
- 15 Nov 2022 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Nov 2022 — PUBLISHED FOR OPPOSITION
- 26 Oct 2022 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 10 Oct 2022 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 10 Oct 2022 — EXAMINER'S AMENDMENT ENTERED
- 10 Oct 2022 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 10 Oct 2022 — EXAMINERS AMENDMENT E-MAILED
- 10 Oct 2022 — EXAMINERS AMENDMENT -WRITTEN
- 10 Sept 2022 — TEAS/EMAIL CORRESPONDENCE ENTERED